Eltrombopag Olamine

Product NDC

69238-1417

11-digit product format

692381417

Labeler code

69238

Product ID

69238-1417_8dba449a-e27a-4f76-a831-6774aa89c217

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Eltrombopag

Dosage form

TABLET, FILM COATED

Route

ORAL

Labeler

Amneal Pharmaceuticals NY LLC

Application

ANDA212884

Marketing category

ANDA

Marketing start

2026-01-15

Substance

ELTROMBOPAG OLAMINE

Active strength

12.5 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist [EPC], Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]

NDC exclude flag

No

Listing certified through

2027-12-31

Current FDA listing

Yes